These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 35131168)
1. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY). Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168 [TBL] [Abstract][Full Text] [Related]
2. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey. Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595 [TBL] [Abstract][Full Text] [Related]
3. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108 [TBL] [Abstract][Full Text] [Related]
4. "Pesto" Mutation: Phenotypic and Genotypic Characteristics of Eight GCK/MODY Ligurian Patients. Salina A; Bassi M; Aloi C; Strati MF; Bocciardi R; d'Annunzio G; Maghnie M; Minuto N Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835446 [TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients. Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978 [TBL] [Abstract][Full Text] [Related]
6. Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG). Peixoto-Barbosa R; Calliari LE; Crispim F; Moisés RS; Dib SA; Reis AF; Giuffrida FMA Arch Endocrinol Metab; 2024; 68():e230314. PubMed ID: 39420902 [TBL] [Abstract][Full Text] [Related]
7. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young. Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527 [TBL] [Abstract][Full Text] [Related]
8. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns. Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926 [TBL] [Abstract][Full Text] [Related]
9. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus. Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753 [TBL] [Abstract][Full Text] [Related]
10. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis. Liu J; Xiao X; Zhang Q; Yu M J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652 [TBL] [Abstract][Full Text] [Related]
11. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations. Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271 [TBL] [Abstract][Full Text] [Related]
12. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)]. Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629 [TBL] [Abstract][Full Text] [Related]
13. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults. Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320 [TBL] [Abstract][Full Text] [Related]
14. Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure. Arslanian S; El Ghormli L; Haymond MH; Chan CL; Chernausek SD; Gandica RG; Gubitosi-Klug R; Levitsky LL; Siska M; Willi SM; Pediatr Diabetes; 2020 Jun; 21(4):575-585. PubMed ID: 32064729 [TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY). Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678 [TBL] [Abstract][Full Text] [Related]
16. Partial GCK gene deletion mutations causing maturity-onset diabetes of the young. Yu R; Zhang H; Xiao X Acta Diabetol; 2024 Jan; 61(1):107-115. PubMed ID: 37704826 [TBL] [Abstract][Full Text] [Related]
17. [Monogenic form of diabetes mellitus due to HNF4α mutation (MODY-1) - the first case in Hungary]. Jermendy G; Balogh I; Gaál Z Orv Hetil; 2016 Mar; 157(12):469-73. PubMed ID: 26971647 [TBL] [Abstract][Full Text] [Related]
18. Maturity-onset diabetes of the young (MODY): an update. Anık A; Çatlı G; Abacı A; Böber E J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges. Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449 [TBL] [Abstract][Full Text] [Related]
20. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA; Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]